VolitionRx Limited
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
12.0M
on 2026-06-30, from 4.11M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-20 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
S-3 of 2024-11-08. Not read yet. S-3 ↗
$30.0M
Agreement of 2025-04-22. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-13 is not read yet.
Cash
0.6 quarters
$2.8M on 2026-06-30 ÷ $4.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-06-07 | Public offering with warrants at $1.55 | 2,960,000 | $1.55 | $4.6M | 424B5 ↗ |
| 2026-01-07 | Private placement | 7,000,350 | $0.5714 | not stated | 8-K ↗ |
| 2025-10-10 | Public offering | 11,550,000 | $0.52 | $6.0M | 424B5 ↗ |
| 2025-08-01 | Public offering | 1,890,625 | $0.64 | $1.2M | 424B5 ↗ |
| 2025-03-24 | Public offering | 4,102,723 | $0.55 | not read | 424B5 ↗ |
Also on file: a 1-for-20 reverse split, 2026-04-28 8-K ↗